MOv19-BBz CAR T Cells in FRa+ Cancers

NCT07116057 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

10

Enrollment

OTHER

Sponsor class

Conditions

Metastatic Non Small Cell Lung Cancer
Recurrent Lung Non-Small Cell Carcinoma

Interventions

BIOLOGICAL: MOv19-BBz CAR T cells
DRUG: Cyclophosphamide/Fludarabine
DEVICE: FRa Expression Testing

Sponsor

University of Pennsylvania

Collaborators

[object Object]